Sumitomo Pharma Oncology, Inc.
Overview
Sumitomo Pharma Oncology, Inc. is a subsidiary of Sumitomo Pharma Co., Ltd., focusing on the research, development, and commercialization of oncology therapeutics. The company is dedicated to providing innovative treatments for patients living with cancer.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Sumitomo Pharma Oncology, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.